Search This Blog

468x60.

728x90

 


Ketoconazole 02-Apr-2019

l INDICATIONS AND DOSE

Tinea pedis

▶ TO THE SKIN USING CREAM

▶ Adult: Apply twice daily

Fungal skin infection (not Tinea pedis)

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day

Treatment of seborrhoeic dermatitis and dandruff

▶ TO THE SKIN USING SHAMPOO

▶ Child 12–17 years: Apply twice weekly for 2–4 weeks,

leave preparation on for 3–5 minutes before rinsing

▶ Adult: Apply twice weekly for 2–4 weeks, leave

preparation on for 3–5 minutes before rinsing

Prophylaxis of seborrhoeic dermatitis and dandruff

▶ TO THE SKIN USING SHAMPOO

▶ Child 12–17 years: Apply every 1–2 weeks, leave

preparation on for 3–5 minutes before rinsing

▶ Adult: Apply every 1–2 weeks, leave preparation on for

3–5 minutes before rinsing

Treatment of pityriasis versicolor

▶ TO THE SKIN USING SHAMPOO

▶ Child 12–17 years: Apply once daily for maximum 5 days,

leave preparation on for 3–5 minutes before rinsing

▶ Adult: Apply once daily for maximum 5 days, leave

preparation on for 3–5 minutes before rinsing

Prophylaxis of pityriasis versicolor

▶ TO THE SKIN USING SHAMPOO

▶ Child 12–17 years: Apply once daily for up to 3 days

before sun exposure, leave preparation on for

3–5 minutes before rinsing

▶ Adult: Apply once daily for up to 3 days before sun

exposure, leave preparation on for 3–5 minutes before

rinsing

l CONTRA-INDICATIONS Acute porphyrias p. 1058

l CAUTIONS Avoid contact with eyes . avoid contact with

mucous membranes

l INTERACTIONS → Appendix 1: antifungals, azoles

l SIDE-EFFECTS

GENERAL SIDE-EFFECTS

▶ Common or very common Skin reactions

▶ Uncommon Alopecia . angioedema . excessive tearing . folliculitis . hair changes

▶ Rare or very rare Eye irritation .taste altered

l NATIONAL FUNDING/ACCESS DECISIONS

NHS restrictions Nizoral ® cream is not prescribable in NHS

primary care except for the treatment of seborrhoeic

dermatitis and pityriasis versicolor; endorse prescription

’SLS’.

l EXCEPTIONS TO LEGAL CATEGORY A 15-g tube is available

for sale to the public for the treatment of tinea pedis, tinea

cruris, and candidal intertrigo.

Can be sold to the public for the prevention and

treatment of dandruff and seborrhoeic dermatitis of the

scalp as a shampoo formulation containing ketoconazole

maximum 2%, in a pack containing maximum 120 mL and

labelled to show a maximum frequency of application of

once every 3 days.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol), polysorbates, propylene glycol

▶ Nizoral (Janssen-Cilag Ltd)

Ketoconazole 20 mg per 1 gram Nizoral 2% cream | 30 gram P £4.24 DT = £4.24

Shampoo

EXCIPIENTS: May contain Imidurea

▶ Ketoconazole (Non-proprietary)

Ketoconazole 20 mg per 1 gram Ketoconazole 2% shampoo | 120 ml P £3.36 DT = £3.36

▶ Dandrazol (Transdermal Ltd)

Ketoconazole 20 mg per 1 gram Dandrazol Anti-dandruff 2%

shampoo | 120 ml P £3.39 DT = £3.36

▶ Nizoral (Janssen-Cilag Ltd, Thornton & Ross Ltd)

Ketoconazole 20 mg per 1 gram Nizoral 2% shampoo | 120 ml P £3.59 DT = £3.36

Miconazole 02-Apr-2019

l INDICATIONS AND DOSE

Fungal skin infections

▶ TO THE SKIN

▶ Child: Apply twice daily continuing for 10 days after

lesions have healed

▶ Adult: Apply twice daily continuing for 10 days after

lesions have healed

Fungal nail infections

▶ TO THE SKIN

▶ Child: Apply 1–2 times a day

▶ Adult: Apply 1–2 times a day

l UNLICENSED USE

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CAUTIONS Avoid in Acute porphyrias p. 1058 . contact with

eyes and mucous membranes should be avoided

l INTERACTIONS → Appendix 1: antifungals, azoles

l SIDE-EFFECTS

▶ Common or very common Skin reactions

▶ Frequency not known Angioedema

l PREGNANCY Absorbed from the skin in small amounts;

manufacturer advises caution.

l BREAST FEEDING Manufacturer advises caution—no

information available.

l PROFESSION SPECIFIC INFORMATION

Dental practitioners’ formulary

Miconazole cream may be prescribed.

l NATIONAL FUNDING/ACCESS DECISIONS

NHS restrictions Daktarin ® powder and Daktarin ® cream

15 g is not prescribable in NHS primary care.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Butylated hydroxyanisole

▶ Daktarin (McNeil Products Ltd, Janssen-Cilag Ltd, Johnson & Johnson

Ltd)

Miconazole nitrate 20 mg per 1 gram Daktarin 2% cream | 15 gram p £2.51 | 30 gram p £1.82 DT = £1.82

Powder

▶ Daktarin (McNeil Products Ltd)

Miconazole nitrate 20 mg per 1 gram Daktarin 2% powder | 20 gram p £2.95 DT = £2.95

Tioconazole

l INDICATIONS AND DOSE

Fungal nail infection

▶ BY TRANSUNGUAL APPLICATION

▶ Child: Apply twice daily usually for up to 6 months

(may be extended to 12 months), apply to nails and

surrounding skin

▶ Adult: Apply twice daily usually for up to 6 months

(may be extended to 12 months), apply to nails and

surrounding skin

BNF 78 Fungal skin infections 1233

Skin

13

l UNLICENSED USE

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CAUTIONS Contact with eyes and mucous membranes

should be avoided . use with caution if child likely to suck

affected digits (in children)

l SIDE-EFFECTS

▶ Common or very common Peripheral oedema

▶ Uncommon Skin reactions

▶ Frequency not known Nail disorder. pain . paraesthesia . periorbital oedema

l PREGNANCY Manufacturer advises avoid.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Paint

▶ Tioconazole (Non-proprietary)

Tioconazole 283 mg per 1 ml Tioconazole 283mg/ml medicated nail

lacquer | 12 ml P £27.38–£28.74 DT = £28.74

▶ Trosyl (Pfizer Ltd)

Tioconazole 283 mg per 1 ml Trosyl 283mg/ml nail solution | 12 ml P £27.38 DT = £28.74

ANTIFUNGALS › OTHER

Amorolfine

l INDICATIONS AND DOSE

Fungal nail infections

▶ BY TRANSUNGUAL APPLICATION

▶ Child 12–17 years: Apply 1–2 times a week for 6 months

to treat finger nails and for toe nails 9–12 months

(review at intervals of 3 months), apply to infected

nails after filing and cleansing, allow to dry for

approximately 3 minutes

▶ Adult: Apply 1–2 times a week for 6 months to treat

finger nails and for toe nails 9–12 months (review at

intervals of 3 months), apply to infected nails after

filing and cleansing, allow to dry for approximately

3 minutes

l CAUTIONS Avoid contact with ears . avoid contact with

eyes and mucous membranes . use with caution in child

likely to suck affected digits

l SIDE-EFFECTS

▶ Rare or very rare Nail discolouration . skin reactions

l PATIENT AND CARER ADVICE Avoid nail varnish or artificial

nails during treatment.

l EXCEPTIONS TO LEGAL CATEGORY

▶ In adults Amorolfine nail lacquer can be sold to the public

if supplied for the treatment of mild cases of distal and

lateral subungual onychomycoses caused by

dermatophytes, yeasts and moulds; subject to treatment of

max. 2 nails, max. strength of nail lacquer amorolfine 5%

and a pack size of 3 mL.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Medicated nail lacquer

CAUTIONARY AND ADVISORY LABELS 10

▶ Amorolfine (Non-proprietary)

Amorolfine (as Amorolfine hydrochloride) 50 mg per

1 ml Amorolfine 5% medicated nail lacquer | 5 ml P £16.21 DT =

£6.14

▶ Loceryl (Galderma (UK) Ltd)

Amorolfine (as Amorolfine hydrochloride) 50 mg per 1 ml Loceryl

5% medicated nail lacquer | 2.5 ml P £7.26 | 5 ml P £9.08 DT

= £6.14

▶ Omicur (Morningside Healthcare Ltd)

Amorolfine (as Amorolfine hydrochloride) 50 mg per 1 ml Omicur

5% medicated nail lacquer | 2.5 ml P £9.09 | 5 ml P £9.09 DT

= £6.14

Griseofulvin 01-Aug-2018

l INDICATIONS AND DOSE

Tinea pedis

▶ TO THE SKIN

▶ Adult: Apply 400 micrograms once daily, apply to an

area approximately 13 cm2

; increased if necessary to

1.2 mg once daily for maximum treatment duration of

4 weeks, allow each spray to dry between application

l CAUTIONS Avoid contact with eyes and mucous

membranes

l INTERACTIONS → Appendix 1: griseofulvin

l SIDE-EFFECTS Paraesthesia . skin irritation

l PREGNANCY Manufacturer advises avoid unless potential

benefit outweighs risk.

l BREAST FEEDING Manufacturer advises avoid unless

potential benefit outweighs risk.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Spray

CAUTIONARY AND ADVISORY LABELS 15

EXCIPIENTS: May contain Benzyl alcohol

▶ Grisol AF (Transdermal Ltd)

Griseofulvin 10 mg per 1 gram Grisol AF 1% spray | 20 ml p £4.00

Terbinafine 23-Apr-2018

l INDICATIONS AND DOSE

Tinea pedis

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day for up to 1 week, to be

applied thinly

▶ BY MOUTH USING TABLETS

▶ Adult: 250 mg once daily for 2-6 weeks

Tinea corporis

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day for up to 1–2 weeks, to be

applied thinly, review treatment after 2 weeks

▶ BY MOUTH USING TABLETS

▶ Adult: 250 mg once daily for 4 weeks

Tinea cruris

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day for up to 1–2 weeks, to be

applied thinly, review treatment after 2 weeks

▶ BY MOUTH USING TABLETS

▶ Adult: 250 mg once daily for 2-4 weeks

Dermatophyte infections of the nails

▶ BY MOUTH USING TABLETS

▶ Adult: 250 mg once daily for 6 weeks-3 months

(occasionally longer in toenail infections)

Cutaneous candidiasis | Pityriasis versicolor

▶ TO THE SKIN USING CREAM

▶ Adult: Apply 1–2 times a day for 2 weeks, to be applied

thinly, review treatment after 2 weeks

l CAUTIONS

▶ With oral use autoimmune disease (risk of lupuserythematosus-like effect). psoriasis (risk of exacerbation)

▶ With topical use contact with eyes and mucous membranes

should be avoided

l INTERACTIONS → Appendix 1: terbinafine

l SIDE-EFFECTS

GENERAL SIDE-EFFECTS

▶ Common or very common Skin reactions

1234 Infections of the skin BNF 78

Skin

13

SPECIFIC SIDE-EFFECTS

▶ Common or very common

▶ With oral use Appetite decreased . arthralgia . diarrhoea . gastrointestinal discomfort. gastrointestinal disorder. headache . myalgia . nausea

▶ Uncommon

▶ With oral use Taste altered . weight decreased

▶ With topical use Pain

▶ Rare or very rare

▶ With oral use Agranulocytosis . alopecia . cutaneous lupus

erythematosus . dizziness . hepatic disorders . malaise . neutropenia . photosensitivity reaction . sensation

abnormal . severe cutaneous adverse reactions (SCARs). systemic lupus erythematosus (SLE).thrombocytopenia . vertigo

▶ Frequency not known

▶ With oral use Anaemia . anxiety . depressive symptom . fatigue . fever. hearing impairment. influenza like illness . pancreatitis . pancytopenia .rhabdomyolysis . serum

sickness-like reaction . smell altered .tinnitus . vasculitis . vision disorders

▶ With topical use Hypersensitivity

SIDE-EFFECTS, FURTHER INFORMATION Liver toxicity With

oral use; discontinue treatment if liver toxicity develops

(including jaundice, cholestasis and hepatitis).

Serious skin reactions With oral use; discontinue

treatment in progressive skin rash (including StevensJohnson syndrome and toxic epidermal necrolysis).

l PREGNANCY

▶ With topical use Manufacturer advises use only if potential

benefit outweighs risk— animal studies suggest no adverse

effects.

▶ With oral use Manufacturer advises use only if potential

benefit outweighs risk—no information available.

l BREAST FEEDING

▶ With topical use Manufacturer advises avoid—present in

milk. Less than 5% of the dose is absorbed after topical

application of terbinafine; avoid application to mother’s

chest.

▶ With oral use Avoid—present in milk.

l HEPATIC IMPAIRMENT

▶ With oral use Manufacturer advises avoid (risk of increased

exposure).

l RENAL IMPAIRMENT

Dose adjustments ▶ With oral use Use half normal dose if

eGFR less than 50 mL/minute/1.73 m2 and no suitable

alternative available.

l MONITORING REQUIREMENTS

▶ With oral use Monitor hepatic function before treatment

and then periodically after 4–6 weeks of treatment—

discontinue if abnormalities in liver function tests.

l PATIENT AND CARER ADVICE

▶ With oral use Manufacturer advises that patients should

immediately report any signs or symptoms suggestive of

liver dysfunction such as pruritus, unexplained persistent

nausea, decreased appetite, anorexia, jaundice, vomiting,

fatigue, right upper abdominal pain, dark urine, or pale

stools. Patients with these symptoms should discontinue

taking terbinafine and the patient’s liver function should

be immediately evaluated.

l EXCEPTIONS TO LEGAL CATEGORY

▶ With topical use Preparations of terbinafine hydrochloride

(maximum 1%) can be sold to the public for use in those

over 16 years for external use for the treatment of tinea

pedis as a cream in a pack containing maximum 15 g, or for

the treatment of tinea pedis and cruris as a cream in a pack

containing maximum 15 g, or for the treatment of tinea

pedis, cruris, and corporis as a spray in a pack containing

maximum 30 mL spray or as a gel in a pack containing

maximum 30 g gel.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Tablet

CAUTIONARY AND ADVISORY LABELS 9

▶ Terbinafine (Non-proprietary)

Terbinafine (as Terbinafine hydrochloride) 250 mg Terbinafine

250mg tablets | 14 tablet P £18.11 DT = £1.20 | 28 tablet P £2.40–£34.93

▶ Lamisil (Novartis Pharmaceuticals UK Ltd)

Terbinafine (as Terbinafine hydrochloride) 250 mg Lamisil 250mg

tablets | 14 tablet P £21.30 DT = £1.20 | 28 tablet P £41.09

Cream

EXCIPIENTS: May contain Benzyl alcohol, cetostearyl alcohol (including

cetyl and stearyl alcohol), polysorbates

▶ Terbinafine (Non-proprietary)

Terbinafine hydrochloride 10 mg per 1 gram Terbinafine 1% cream

| 15 gram P £3.17 DT = £1.27 | 30 gram P £6.33 DT = £2.54

▶ Lamisil (GlaxoSmithKline Consumer Healthcare)

Terbinafine hydrochloride 10 mg per 1 gram Lamisil 1% cream | 30 gram P £8.76 DT = £2.54

ANTISEPTICS AND DISINFECTANTS ›

UNDECENOATES

Undecenoic acid with zinc

undecenoate

l INDICATIONS AND DOSE

Treatment of athletes foot

▶ TO THE SKIN

▶ Child: Apply twice daily, continue use for 7 days after

lesions have healed

▶ Adult: Apply twice daily, continue use for 7 days after

lesions have healed

Prevention of athletes foot

▶ TO THE SKIN

▶ Child: Apply once daily

▶ Adult: Apply once daily

l UNLICENSED USE

▶ In children Mycota ® licensed for use in children (age range

not specified by manufacturer).

l CAUTIONS Avoid broken skin . contact with eyes should be

avoided . contact with mucous membranes should be

avoided

l SIDE-EFFECTS

▶ Rare or very rare Skin irritation

SIDE-EFFECTS, FURTHER INFORMATION Treatment should

be discontinued if irritation is severe.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol), fragrances

▶ Mycota (zinc undecenoate / undecenoic acid) (Thornton & Ross

Ltd)

Undecenoic acid 50 mg per 1 gram, Zinc undecenoate 200 mg per

1 gram Mycota cream | 25 gram G £2.01

Powder

EXCIPIENTS: May contain Fragrances

▶ Mycota (zinc undecenoate / undecenoic acid) (Thornton & Ross

Ltd)

Undecenoic acid 20 mg per 1 gram, Zinc undecenoate 200 mg per

1 gram Mycota powder | 70 gram G £3.04

BNF 78 Fungal skin infections 1235

Skin

13

ANTISEPTICS AND DISINFECTANTS › OTHER

Chlorhexidine with nystatin

l INDICATIONS AND DOSE

Skin infections due to Candida spp.

▶ TO THE SKIN

▶ Child: Apply 2–3 times a day, continuing for 7 days

after lesions have healed

▶ Adult: Apply 2–3 times a day, continuing for 7 days

after lesions have healed

l UNLICENSED USE

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CAUTIONS Avoid contact with eyes and mucous

membranes

l SIDE-EFFECTS Hypersensitivity . skin reactions

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

EXCIPIENTS: May contain Benzyl alcohol, cetostearyl alcohol (including

cetyl and stearyl alcohol), polysorbates

▶ Chlorhexidine with nystatin (Non-proprietary)

Chlorhexidine hydrochloride 10 mg per 1 gram, Nystatin

100000 unit per 1 gram Nystatin 100,000units/g / Chlorhexidine

hydrochloride 1% cream | 30 gram P £4.99 DT = £4.99

BENZOATES

Benzoic acid with salicylic acid

l INDICATIONS AND DOSE

Ringworm (tinea)

▶ TO THE SKIN

▶ Child: Apply twice daily

▶ Adult: Apply twice daily

l UNLICENSED USE

▶ In children Licensed for use in children (age range not

specified by manufacturer).

l CAUTIONS Avoid broken or inflamed skin . avoid contact

with eyes . avoid contact with mucous membranes

CAUTIONS, FURTHER INFORMATION

▶ Salicylate toxicity Salicylate toxicity may occur particularly

if applied on large areas of skin.

l SIDE-EFFECTS Hypersensitivity . skin burning sensation

(mild). skin reactions

SIDE-EFFECTS, FURTHER INFORMATION Treatment should

be discontinued if side effects are severe.

l PRESCRIBING AND DISPENSING INFORMATION Benzoic

Acid Ointment, Compound, BP has also been referred to as

Whitfield’s ointment.

l MEDICINAL FORMS Forms available from special-order

manufacturers include: cream, ointment

2.3 Parasitic skin infections

Other drugs used for Parasitic skin infections Ivermectin,

p. 604

PARASITICIDES

Benzyl benzoate

l INDICATIONS AND DOSE

Scabies

▶ TO THE SKIN

▶ Adult: Apply over the whole body; repeat without

bathing on the following day and wash off 24 hours

later; a third application may be required in some cases

l CAUTIONS Avoid contact with eyes and mucous

membranes . children (not recommended). do not use on

broken or secondarily infected skin

l SIDE-EFFECTS Skin burning sensation (especially on

genitalia and excoriations). skin reactions

l BREAST FEEDING Suspend feeding until product has been

washed off.

l PRESCRIBING AND DISPENSING INFORMATION When

prepared extemporaneously, the BP states Benzyl

Benzoate Application, BP consists of benzyl benzoate 25%

in an emulsion basis.

Some manufacturers recommend application to the

body but to exclude the head and neck. However,

application should be extended to the scalp, neck, face,

and ears. Note—dilution to reduce irritant effect also

reduces efficacy.

l LESS SUITABLE FOR PRESCRIBING Benzyl benzoate is less

suitable for prescribing.

l MEDICINAL FORMS Forms available from special-order

manufacturers include: liquid

Dimeticone 06-Apr-2018

l INDICATIONS AND DOSE

Head lice

▶ TO THE SKIN

▶ Child: Apply once weekly for 2 doses, rub into dry hair

and scalp, allow to dry naturally, shampoo after

minimum 8 hours (or overnight)

▶ Adult: Apply once weekly for 2 doses, rub into dry hair

and scalp, allow to dry naturally, shampoo after

minimum 8 hours (or overnight)

l UNLICENSED USE

▶ In children Not licensed for use in children under 6 months

except under medical supervision.

IMPORTANT SAFETY INFORMATION

MHRA/CHM ADVICE: HEAD LICE ERADICATION PRODUCTS: RISK OF

SERIOUS BURNS IF TREATED HAIR IS EXPOSED TO OPEN FLAMES

OR OTHER SOURCES OF IGNITION (MARCH 2018)

See Skin infections p. 1228.

l CAUTIONS Avoid contact with eyes . children under

6 months, medical supervision required

l SIDE-EFFECTS Alopecia . dyspnoea . eye irritation . hypersensitivity . scalp changes . skin reactions

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Liquid

▶ Hedrin (Thornton & Ross Ltd)

Dimeticone 40 mg per 1 gram Hedrin 4% lotion | 50 ml p £3.28

DT = £3.28 | 150 ml p £7.62 DT = £7.62

Cutaneous spray solution

▶ Hedrin (Thornton & Ross Ltd)

Dimeticone 40 mg per 1 gram Hedrin 4% spray | 120 ml G £7.85

1236 Infections of the skin BNF 78

Skin

13

Malathion 06-Apr-2018

l INDICATIONS AND DOSE

Head lice

▶ TO THE SKIN

▶ Child: Apply once weekly for 2 doses, rub preparation

into dry hair and scalp, allow to dry naturally, remove

by washing after 12 hours

▶ Adult: Apply once weekly for 2 doses, rub preparation

into dry hair and scalp, allow to dry naturally, remove

by washing after 12 hours

Crab lice

▶ TO THE SKIN

▶ Child: Apply once weekly for 2 doses, apply preparation

over whole body, allow to dry naturally, wash off after

12 hours or overnight

▶ Adult: Apply once weekly for 2 doses, apply

preparation over whole body, allow to dry naturally,

wash off after 12 hours or overnight

Scabies

▶ TO THE SKIN

▶ Child: Apply once weekly for 2 doses, apply preparation

over whole body, and wash off after 24 hours, if hands

are washed with soap within 24 hours, they should be

retreated

▶ Adult: Apply once weekly for 2 doses, apply

preparation over whole body, and wash off after

24 hours, if hands are washed with soap within

24 hours, they should be retreated

l UNLICENSED USE

▶ In children Not licensed for use in children under 6 months

except under medical supervision.

IMPORTANT SAFETY INFORMATION

MHRA/CHM ADVICE: HEAD LICE ERADICATION PRODUCTS: RISK OF

SERIOUS BURNS IF TREATED HAIR IS EXPOSED TO OPEN FLAMES

OR OTHER SOURCES OF IGNITION (MARCH 2018)

See Skin infections p. 1228.

l CAUTIONS Alcoholic lotions not recommended for head

lice in children with severe eczema or asthma, or for

scabies or crab lice . avoid contact with eyes . children

under 6 months, medical supervision required . do not use

lotion more than once a week for 3 consecutive weeks . do

not use on broken or secondarily infected skin

l SIDE-EFFECTS Angioedema . eye swelling . hypersensitivity . skin reactions

l PRESCRIBING AND DISPENSING INFORMATION For scabies,

manufacturer recommends application to the body but not

necessarily to the head and neck. However, application

should be extended to the scalp, neck, face, and ears.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Liquid

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol), fragrances, hydroxybenzoates (parabens)

▶ Derbac-M (G.R. Lane Health Products Ltd)

Malathion 5 mg per 1 gram Derbac-M 0.5% liquid | 50 ml p £4.26

DT = £4.26 | 200 ml p £9.91 DT = £9.91

Permethrin 12-Apr-2018

l INDICATIONS AND DOSE

Scabies

▶ TO THE SKIN

▶ Child: Apply once weekly for 2 doses, apply 5%

preparation over whole body including face, neck, scalp

and ears then wash off after 8–12 hours. If hands are

washed with soap within 8 hours of application, they

should be treated again with cream

▶ Adult: Apply once weekly for 2 doses, apply 5%

preparation over whole body including face, neck, scalp

and ears then wash off after 8–12 hours. If hands are

washed with soap within 8 hours of application, they

should be treated again with cream

Crab lice

▶ TO THE SKIN

▶ Adult: Apply once weekly for 2 doses, apply 5% cream

over whole body, allow to dry naturally and wash off

after 12 hours or after leaving on overnight

Head lice

▶ TO THE SKIN

▶ Adult: Not recommended; no information given

l UNLICENSED USE

▶ In children Dermal Cream (scabies), not licensed for use in

children under 2 months; not licensed for treatment of

crab lice in children under 18 years. Creme Rinse (head lice)

not licensed for use in children under 6 months except

under medical supervision.

IMPORTANT SAFETY INFORMATION

MHRA/CHM ADVICE: HEAD LICE ERADICATION PRODUCTS: RISK OF

SERIOUS BURNS IF TREATED HAIR IS EXPOSED TO OPEN FLAMES

OR OTHER SOURCES OF IGNITION (MARCH 2018)

See Skin infections p. 1228.

l CAUTIONS Avoid contact with eyes . children aged

2 months–2 years, medical supervision required for dermal

cream (scabies). children under 6 months, medical

supervision required for cream rinse (head lice). do not use

on broken or secondarily infected skin

l SIDE-EFFECTS Scalp irritation . skin reactions

l PRESCRIBING AND DISPENSING INFORMATION

Manufacturer recommends application to the body but to

exclude head and neck. However, application should be

extended to the scalp, neck, face, and ears.

Larger patients may require up to two 30-g packs for

adequate treatment.

l LESS SUITABLE FOR PRESCRIBING Lyclear ® Creme Rinse is

less suitable for prescribing.

l MEDICINAL FORMS There can be variation in the licensing of

different medicines containing the same drug.

Cream

CAUTIONARY AND ADVISORY LABELS 10 (Dermal cream only)

EXCIPIENTS: May contain Butylated hydroxytoluene, woolfat and related

substances (including lanolin)

▶ Permethrin (Non-proprietary)

Permethrin 50 mg per 1 gram Permethrin 5% cream | 30 gram p

£7.46 DT = £7.28

▶ Lyclear (Omega Pharma Ltd)

Permethrin 50 mg per 1 gram Lyclear 5% dermal cream | 30 gram p £5.73 DT = £7.28

Liquid

EXCIPIENTS: May contain Cetostearyl alcohol (including cetyl and

stearyl alcohol)

▶ Lyclear (Omega Pharma Ltd)

Permethrin 10 mg per 1 gram Lyclear 1% creme rinse | 59 ml p

£4.20 DT = £4.20 | 118 ml p £6.79 DT = £6.79

BNF 78 Parasitic skin infections 1237

Skin

13

No comments:

Post a Comment

اكتب تعليق حول الموضوع

mcq general

 

Search This Blog